共 44 条
[1]
Goldhirsch A.(2006)Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 17 878-879
[2]
Glick J.H.(1999)Molecular genetics and epidemiology of prostate carcinoma Endocr Rev 20 22-45
[3]
Gelber R.D.(1996)Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer Br J Cancer 74 1175-1180
[4]
Ruijiter E.(1996)The clinical significance of androgen receptors in breast cancer and their relation to histopathological and cell biological parameters Eur J Cancer 32A 1560-1565
[5]
van de Kaa C.(1991)Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis Cancer 67 886-891
[6]
Miller G.(1960)Androgens and estrogens in the treatment of disseminated mammary carcinoma JAMA 172 1271-1274
[7]
Hall R.E.(2005)General rules for clinical and pathological recording of breast cancer 2005 Breast Cancer 12 s1-s14
[8]
Aspinall J.O.(1991)Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403-410
[9]
Horsfall D.J.(2003)Endocrine and interaction sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone Endocr Rev 24 152-182
[10]
Kuenen-Boumeester V.(2004)Testosterone effects on the breast: implications for testosterone therapy for women Endocr Rev 25 374-388